Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco

K. Rebbani, A. Ouladlahsen, A. Bensghir, Abdellah Akil, H. Lamdini, H. Issouf, I. Brahim, B. Kitab, F. Z. Fakhir, L. Wakrim, K. Marhoum El Filali, H. Himmich, S. Ezzikouri, S. Benjelloun

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are major public health concerns. We aimed to determine the prevalence of HBV and HCV infections among HIV-infected patients, and to identify the main circulating hepatitis strains in Morocco. The study was carried out in 503 HIV-infected patients. Our survey indicated that the prevalence of HIV/hepatitis co-infection was 10.6%; 5.2% of patients were HBV surface antigen positive, and 5.4% of patients were anti-HCV positive. Among the HBV surface antigen-positive group, HBV DNA sequencing identified exclusively genotype D (D1: 26.7%; D7: 73.3%) in accordance with what is found in the general population. In contrast, sequencing of HCV isolates produced an unusual subtype distribution with a decreasing order of prevalence: 1a, 3a (both 23.5%), 1b, 4a (both 17.6%), 1c (11.8%) and 6h (6%).

Original languageEnglish (US)
JournalClinical Microbiology and Infection
Volume19
Issue number10
DOIs
StatePublished - Oct 2013
Externally publishedYes

Fingerprint

Morocco
Coinfection
Hepatitis B virus
Hepacivirus
HIV
Hepatitis B Surface Antigens
Hepatitis
Virus Diseases
DNA Sequence Analysis
Public Health
Genotype
Population

Keywords

  • Chronic hepatitis
  • Co-infection
  • Genotype
  • Human immunodeficiency virus
  • Prevalence

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco. / Rebbani, K.; Ouladlahsen, A.; Bensghir, A.; Akil, Abdellah; Lamdini, H.; Issouf, H.; Brahim, I.; Kitab, B.; Fakhir, F. Z.; Wakrim, L.; Marhoum El Filali, K.; Himmich, H.; Ezzikouri, S.; Benjelloun, S.

In: Clinical Microbiology and Infection, Vol. 19, No. 10, 10.2013.

Research output: Contribution to journalArticle

Rebbani, K, Ouladlahsen, A, Bensghir, A, Akil, A, Lamdini, H, Issouf, H, Brahim, I, Kitab, B, Fakhir, FZ, Wakrim, L, Marhoum El Filali, K, Himmich, H, Ezzikouri, S & Benjelloun, S 2013, 'Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco', Clinical Microbiology and Infection, vol. 19, no. 10. https://doi.org/10.1111/1469-0691.12252
Rebbani, K. ; Ouladlahsen, A. ; Bensghir, A. ; Akil, Abdellah ; Lamdini, H. ; Issouf, H. ; Brahim, I. ; Kitab, B. ; Fakhir, F. Z. ; Wakrim, L. ; Marhoum El Filali, K. ; Himmich, H. ; Ezzikouri, S. ; Benjelloun, S. / Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco. In: Clinical Microbiology and Infection. 2013 ; Vol. 19, No. 10.
@article{f65f0bd89d61441590a0225d1cbe33a3,
title = "Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco",
abstract = "Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are major public health concerns. We aimed to determine the prevalence of HBV and HCV infections among HIV-infected patients, and to identify the main circulating hepatitis strains in Morocco. The study was carried out in 503 HIV-infected patients. Our survey indicated that the prevalence of HIV/hepatitis co-infection was 10.6{\%}; 5.2{\%} of patients were HBV surface antigen positive, and 5.4{\%} of patients were anti-HCV positive. Among the HBV surface antigen-positive group, HBV DNA sequencing identified exclusively genotype D (D1: 26.7{\%}; D7: 73.3{\%}) in accordance with what is found in the general population. In contrast, sequencing of HCV isolates produced an unusual subtype distribution with a decreasing order of prevalence: 1a, 3a (both 23.5{\%}), 1b, 4a (both 17.6{\%}), 1c (11.8{\%}) and 6h (6{\%}).",
keywords = "Chronic hepatitis, Co-infection, Genotype, Human immunodeficiency virus, Prevalence",
author = "K. Rebbani and A. Ouladlahsen and A. Bensghir and Abdellah Akil and H. Lamdini and H. Issouf and I. Brahim and B. Kitab and Fakhir, {F. Z.} and L. Wakrim and {Marhoum El Filali}, K. and H. Himmich and S. Ezzikouri and S. Benjelloun",
year = "2013",
month = "10",
doi = "10.1111/1469-0691.12252",
language = "English (US)",
volume = "19",
journal = "Clinical Microbiology and Infection",
issn = "1198-743X",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Co-infections with hepatitis B and C viruses in human immunodeficiency virus-infected patients in Morocco

AU - Rebbani, K.

AU - Ouladlahsen, A.

AU - Bensghir, A.

AU - Akil, Abdellah

AU - Lamdini, H.

AU - Issouf, H.

AU - Brahim, I.

AU - Kitab, B.

AU - Fakhir, F. Z.

AU - Wakrim, L.

AU - Marhoum El Filali, K.

AU - Himmich, H.

AU - Ezzikouri, S.

AU - Benjelloun, S.

PY - 2013/10

Y1 - 2013/10

N2 - Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are major public health concerns. We aimed to determine the prevalence of HBV and HCV infections among HIV-infected patients, and to identify the main circulating hepatitis strains in Morocco. The study was carried out in 503 HIV-infected patients. Our survey indicated that the prevalence of HIV/hepatitis co-infection was 10.6%; 5.2% of patients were HBV surface antigen positive, and 5.4% of patients were anti-HCV positive. Among the HBV surface antigen-positive group, HBV DNA sequencing identified exclusively genotype D (D1: 26.7%; D7: 73.3%) in accordance with what is found in the general population. In contrast, sequencing of HCV isolates produced an unusual subtype distribution with a decreasing order of prevalence: 1a, 3a (both 23.5%), 1b, 4a (both 17.6%), 1c (11.8%) and 6h (6%).

AB - Human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are major public health concerns. We aimed to determine the prevalence of HBV and HCV infections among HIV-infected patients, and to identify the main circulating hepatitis strains in Morocco. The study was carried out in 503 HIV-infected patients. Our survey indicated that the prevalence of HIV/hepatitis co-infection was 10.6%; 5.2% of patients were HBV surface antigen positive, and 5.4% of patients were anti-HCV positive. Among the HBV surface antigen-positive group, HBV DNA sequencing identified exclusively genotype D (D1: 26.7%; D7: 73.3%) in accordance with what is found in the general population. In contrast, sequencing of HCV isolates produced an unusual subtype distribution with a decreasing order of prevalence: 1a, 3a (both 23.5%), 1b, 4a (both 17.6%), 1c (11.8%) and 6h (6%).

KW - Chronic hepatitis

KW - Co-infection

KW - Genotype

KW - Human immunodeficiency virus

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84884715879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884715879&partnerID=8YFLogxK

U2 - 10.1111/1469-0691.12252

DO - 10.1111/1469-0691.12252

M3 - Article

VL - 19

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 10

ER -